Hospitals & Health Systems

As staffing crises cripple New England hospitals, York Hospital's partnership with ShiftMed offers a tech-driven fix. But is the gig model the ultimate cure?

Phase 2a data shows a new drug not only stops bone-destroying cancer but heals the damage, with no adverse events. This is a strategic game-changer.

A health tech firm's new security certification is more than a press release. It's a blueprint for protecting our most vulnerable in a digital age.

Vivian Health's new AI promises to find nurses 12x faster. But as technology races to fill empty hospital shifts, is it a cure or just a high-tech band-aid?

As Vivos Therapeutics pitches its revolutionary sleep apnea solution to investors, it's not just selling a device; it's fighting for its financial life.

With Bill S-228, Canada is criminalizing forced sterilization. It’s more than a new law; it’s a reckoning with a dark history and a test of reconciliation.

A rare endowed chair at a community hospital, backed by the powerful Boswell Foundation, positions Huntington Health and its new leader for a new era.

Beyond the celebration, Republic Bank’s annual Juneteenth event is a model for corporate impact, tackling health disparities and boosting local entrepreneurs.

A deadly, vaccine-less Ebola strain is spreading in Central Africa. As governments scramble, the CDC Foundation deploys its most potent weapon: agile funding.

Lifelong's star-studded gala promises queer joy and fundraising, but it's a high-stakes test of a new model for a city facing a deepening resource gap.

New research from Baycrest unmasks paratonia, an involuntary condition often mistaken as defiance, signaling a seismic shift in dementia care and treatment.

As dementia costs Ontario $30 billion annually, a new task force is not just another committee. It's a strategic blueprint for dismantling a broken system.

As Capricor presents its late-stage DMD drug and novel exosome platform, can it convince investors it has the key to both patient impact and market success?

An aging world and failing antibiotics are driving a surge in pneumonia. Now, a new generation of therapies is being built to fight back. Here's how.

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

A new partnership between PAM Health and Marshall Health Network isn't just building a hospital; it's creating a new healthcare and economic hub for South Point.

Ottawa's first national eye care strategy isn't just about health. It's a calculated investment in economic resilience and systemic stability for an aging nation.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.